Furthermore, there was a significant association between bone marrow CK20 positivity and overall survival (p = 0.013), as well as bone marrow CK20 positivity and tumor-specific survival (p = 0.041) in this patient cohort (Figure 5). This evidence concerns the gene KRT20 and neoplasm.